“Omnichannel” – the marketing strategy buzzword that has pervaded the space in the last several years – literally means “in every channel”; in effect, making sure a brand or message is ever
The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.